Patents by Inventor Peter William Andrew

Peter William Andrew has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240160457
    Abstract: A multi-user collaboration system, and a method of providing the same are disclosed. The method involves creating a workspace to which a plurality of digital materials can be shared by one or more internal users; receiving, from an internal user of the one or more internal users, an external collaboration request to collaborate with an external user type; in response to receiving the external collaboration request: creating a sub-workspace in association with the workspace for the external user type; and assigning a sub-workspace user group to the sub-workspace; and displaying a set of feedback on the one or more digital materials to a user. The sub-workspace is accessible by an external user associated with the external user type to provide a sub-workspace feedback in respect of one or more digital materials of the plurality of digital materials shared to the sub-workspace.
    Type: Application
    Filed: November 14, 2023
    Publication date: May 16, 2024
    Inventors: Adam Michael KEATING, Jeremy William Andrews, Peter Jeffrey GOSSE, Levin Stanley MEJIA-KING, Robert Raymond Graham PERCY
  • Publication number: 20160130224
    Abstract: There are provided inter alia novel N-phenyl substituted pyrrole derivativesand theiruse in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
    Type: Application
    Filed: June 4, 2014
    Publication date: May 12, 2016
    Inventors: Peter William ANDREW, Mafalda Pires DAMASO, Mark William DAVIES, Fritz-Frieder FRICKEL, Daniel HAMZA, Simon Christopher HIRST, Rana LONNEN
  • Publication number: 20160120864
    Abstract: There is provided inter alia novel N-phenyl substituted pyrrole derivatives and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
    Type: Application
    Filed: June 4, 2014
    Publication date: May 5, 2016
    Inventors: Peter William ANDREW, Mafalda Pires DAMASO, Mark William DAVIES, Fritz-Frieder FRICKEL, Rana LONNEN, Daniel HAMZA, Simon Christopher HIRST
  • Publication number: 20160046576
    Abstract: There are provided inter alia compounds of formula (I) wherein R1, R2, R3, R4a and R4b are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
    Type: Application
    Filed: October 30, 2015
    Publication date: February 18, 2016
    Inventors: Peter William Andrew, Rana Lonnen, Mafalda Pires Damaso, Fritz-Frieder Frickel, Simon Christopher Hirst, Mark William Davies, Daniel Hamza
  • Patent number: 9221756
    Abstract: There are provided inter alia compounds of formula (I) wherein R1, R2, R3, R4a and R4b are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
    Type: Grant
    Filed: December 5, 2012
    Date of Patent: December 29, 2015
    Assignee: University of Leicester
    Inventors: Peter William Andrew, Rana Lonnen, Fritz-Frieder Frickel, Simon Christopher Hirst, Mark William Davies, Daniel Hamza
  • Publication number: 20140309193
    Abstract: There are provided inter alia compounds of formula (I) wherein R1, R2, R3, R4a and R4b are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
    Type: Application
    Filed: December 5, 2012
    Publication date: October 16, 2014
    Inventors: Peter William Andrew, Rana Lonnen, Mafalda Pires Damaso, Fritz-Frieder Frickel, Simon Christopher Hirst, Mark William Davies, Daniel Hamza
  • Patent number: 6716432
    Abstract: Mutants of pneumolysin that are non-toxic by reason of amino acid substitutions have been constructed. These mutants elicit an immune response in animals that is reactive to wild-type pneumolysin. The invention also encompasses vaccines for humans based on these mutants, including vaccines comprising conjugates with pneumococcal capsular polysaccharides.
    Type: Grant
    Filed: January 25, 1995
    Date of Patent: April 6, 2004
    Inventors: James Cleland Paton, David John Hansman, Graham John Boulnois, Peter William Andrew, Timothy John Mitchell, John Arthur Walker